All-Atom
Contacts
Clashscore, all atoms:0.88 100th percentile* (N=576, 2.10Å ± 0.25Å)
Clashscore is the number of serious steric overlaps (> 0.4 Å) per 1000 atoms.
Protein
Geometry
Poor rotamers92.91% Goal: <1%
Ramachandran outliers20.58% Goal: <0.05%
Ramachandran favored32795.61% Goal: >98%
MolProbity score^1.4399th percentile* (N=11758, 2.10Å ± 0.25Å)
Cβ deviations >0.25Å10.30% Goal: 0
Bad backbone bonds:0 / 13890.00% Goal: 0%
Bad backbone angles:1 / 17310.06% Goal: <0.1%
In the two column results, the left column gives the raw count, right column gives the percentage.
* 100th percentile is the best among structures of comparable resolution; 0th percentile is the worst. For clashscore the comparative set of structures was selected in 2004, for MolProbity score in 2006.
^ MolProbity score combines the clashscore, rotamer, and Ramachandran evaluations into a single score, normalized to be on the same scale as X-ray resolution.

Live sorting requires JavaScript enabled and Safari 2, Firefox 1.5, or IE 6

#ResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengths.Bond angles.
Avg: 40.25Clashscore: 0.88Outliers: 2 of 342Poor rotamers: 9 of 309Outliers: 1 of 335Outliers: 0 of 348Outliers: 1 of 348
A 45 ASP64.46--15.5% (t0)
chi angles: 199.4,139.9
0.082Å--
A 46 ASN72.99-Favored (41.54%)
General case / -57.7,-21.6
7.3% (p30)
chi angles: 61.7,93.8
0.018Å--
A 47 GLN49.3-Favored (61.06%)
General case / -73.6,-18.4
24.2% (mt-30)
chi angles: 294.8,170.3,134.6
0.035Å--
A 48 PHE29.44-Favored (19.49%)
General case / -112.0,158.5
81.9% (m-85)
chi angles: 301.1,86.7
0.026Å--
A 49 TYR29.97-Favored (40.01%)
General case / -141.8,149.2
14.2% (p90)
chi angles: 79.1,102.1
0.127Å--
A 50 SER39.53-Favored (42.51%)
General case / -101.5,135.7
58.3% (m)
chi angles: 291
0.078Å--
A 51 VAL42.29-Favored (49.14%)
Isoleucine or valine / -124.5,140.0
0%
chi angles: 261.2
0.202Å--
A 52 GLU94.32-Favored (20.99%)
General case / -82.2,114.8
14.3% (tp10)
chi angles: 201.7,57.9,50.8
0.038Å--
A 53 VAL50.110.544Å
HG13 with A 69 PRO HG3
Allowed (1.5%)
Isoleucine or valine / -121.0,89.9
59.7% (t)
chi angles: 171
0.161Å--
A 54 GLY57.03-Favored (3.79%)
Glycine / 67.0,-111.0
----
A 55 ASP77.24-Favored (19.33%)
General case / -97.2,-18.3
7.8% (p-10)
chi angles: 61.6,102.8
0.032Å--
A 56 SER59.05-Favored (17.86%)
General case / -93.0,154.9
16% (t)
chi angles: 189.7
0.012Å--
A 57 THR41.84-Favored (51%)
General case / -109.7,124.3
53.4% (m)
chi angles: 304.7
0.091Å--
A 58 PHE24.41-Favored (25.75%)
General case / -98.7,113.6
2.7% (m-85)
chi angles: 261.9,63.1
0.025Å--
A 59 THR27.2-Favored (8.54%)
General case / -106.1,98.9
38.4% (m)
chi angles: 305.9
0.15Å--
A 60 VAL22.09-Favored (15.39%)
Isoleucine or valine / -118.7,164.0
23.4% (m)
chi angles: 302.5
0.105Å--
A 61 LEU23.49-Favored (58.75%)
General case / -63.6,139.3
46.3% (mt)
chi angles: 288.2,162.2
0.074Å--
A 62 LYS33.89-Favored (17.78%)
General case / -57.9,-17.6
87.3% (mttt)
chi angles: 285,171.3,169.3,171.4
0.116Å--
A 63 ARG26.82-Favored (67.08%)
General case / -64.2,-22.8
16.7% (ptm180)
chi angles: 66.9,182.8,287,171.1
0.024Å--
A 64 TYR23.34-Favored (28.08%)
General case / -96.7,115.8
47.5% (m-85)
chi angles: 303.2,119.3
0.025Å--
A 65 GLN57.24-Favored (31.92%)
General case / -123.8,158.3
37.7% (mt-30)
chi angles: 288.9,152.1,26.9
0.066Å--
A 66 ASN55.84-Favored (10.32%)
General case / 53.6,54.2
3.6% (t-20)
chi angles: 194.8,216.9
0.065Å--
A 67 LEU25.68-Favored (47.51%)
General case / -62.9,131.1
6% (mp)
chi angles: 265.7,74.1
0.123Å--
A 68 LYS93.86-Favored (16.7%)
Pre-proline / -133.7,122.5
69.9% (mttt)
chi angles: 299,202.7,169.7,192.1
0.037Å--
A 69 PRO32.940.544Å
HG3 with A 53 VAL HG13
Favored (74.64%)
Trans proline / -59.6,137.0
24.4% (Cg_exo)
chi angles: 342.7,29,91.8
0.046Å--
A 70 ILE23.57-Favored (4.26%)
Isoleucine or valine / -127.0,-2.1
40.6% (pt)
chi angles: 57,169.5
0.167Å--
A 71 GLY23.19-Favored (8.79%)
Glycine / 151.3,159.3
----
A 72 SER30.07-Favored (37.48%)
General case / -144.4,162.0
86.2% (p)
chi angles: 61.3
0.016Å--
A 73 GLY27.25-Favored (18.41%)
Glycine / -149.9,-171.5
----
A 74 ALA32.72-Favored (74.31%)
General case / -61.4,-33.8
-0.019Å--
A 75 GLN38.66-Favored (39.08%)
General case / -79.2,-37.1
5.7% (tt0)
chi angles: 208.7,206.7,7
0.052Å--
A 76 GLY28.29-Favored (45.38%)
Glycine / 177.3,176.4
----
A 77 ILE40.44-Favored (21.05%)
Isoleucine or valine / -97.1,138.8
14% (mm)
chi angles: 316.8,298.3
0.036Å--
A 78 VAL15.41-Favored (66.04%)
Isoleucine or valine / -119.7,133.6
32.1% (t)
chi angles: 186
0.104Å--
A 79 CYS24.08-Favored (34.78%)
General case / -119.7,154.0
54.4% (m)
chi angles: 284.3
0.008Å--
A 80 ALA20.58-Favored (22.98%)
General case / -96.9,148.4
-0.146Å--
A 81 ALA20.97-Favored (36.75%)
General case / -159.0,161.8
-0.056Å--
A 82 TYR37.48-Favored (43.91%)
General case / -100.3,123.0
42.8% (t80)
chi angles: 171.3,62.9
0.051Å--
A 83 ASP24.24-Favored (16.44%)
General case / -91.0,103.8
60.3% (t0)
chi angles: 178.3,173.4
0.035Å--
A 84 ALA30.11-Favored (67.29%)
General case / -64.1,-23.3
-0.029Å--
A 85 VAL32.61-Favored (29.67%)
Isoleucine or valine / -76.3,-47.7
40.4% (t)
chi angles: 166.5
0.12Å--
A 86 LEU32.25-Favored (39.81%)
General case / -84.9,-16.9
80.2% (mt)
chi angles: 289.4,175.4
0.094Å--
A 87 ASP53.82-Favored (7.8%)
General case / 59.4,50.3
21.9% (t0)
chi angles: 180.5,43.7
0.079Å--
A 88 ARG72.68-Favored (31.75%)
General case / -145.8,147.4
0.1%
chi angles: 233.9,175.6,138.6,169.4
0.225Å--
A 89 ASN39.61-Favored (32.58%)
General case / -84.1,139.3
79.4% (m-20)
chi angles: 297.9,304.5
0.024Å--
A 90 VAL15.95-Favored (37.21%)
Isoleucine or valine / -129.3,162.2
35.7% (m)
chi angles: 297.8
0.08Å--
A 91 ALA14.89-Favored (54.26%)
General case / -109.8,132.3
-0.088Å--
A 92 ILE21.28-Favored (64.49%)
Isoleucine or valine / -120.2,120.9
48.1% (mt)
chi angles: 308.4,173.8
0.044Å--
A 93 LYS28.44-Favored (54.13%)
General case / -105.9,129.0
34.7% (ttpt)
chi angles: 179.7,160.9,78.2,175.8
0.017Å--
A 94 LYS28.92-Favored (47.49%)
General case / -101.3,130.7
78.7% (tttt)
chi angles: 180.2,191.7,179.6,188.4
0.035Å--
A 95 LEU18.9-Favored (19.89%)
General case / -110.6,109.5
80.8% (mt)
chi angles: 302.5,180.3
0.036Å--
A 96 SER40.79-Favored (25.77%)
General case / -88.2,115.6
4.7% (m)
chi angles: 315.2
0.041Å--
A 97 ARG36.96-Favored (9.07%)
Pre-proline / 44.1,62.9
73.4% (mtp85)
chi angles: 302.8,183.7,65.1,83
0.075Å--
A 98 PRO19.19-Favored (66.82%)
Trans proline / -60.6,-20.9
38.7% (Cg_endo)
chi angles: 23.5,322.9,155.7
0.041Å--
A 99 PHE23.94-Favored (26.2%)
General case / -80.4,2.1
21.6% (p90)
chi angles: 50,79.9
0.018Å--
A 100 GLN35.38-Favored (67.61%)
General case / -56.8,-34.5
10.1% (pt20)
chi angles: 65.4,186.6,267.4
0.139Å--
A 101 ASN32.77-Favored (30.36%)
General case / -149.2,165.9
22.6% (p30)
chi angles: 62.5,63.5
0.113Å--
A 102 GLN70.98-Favored (68.46%)
General case / -53.6,-43.2
2.6% (tp-100)
chi angles: 212.3,78.5,209.3
0.01Å--
A 103 THR43.31-Favored (35.95%)
General case / -64.7,-54.2
19.5% (m)
chi angles: 310.6
0.134Å--
A 104 HIS37.66-Favored (95.02%)
General case / -64.3,-40.0
56.7% (m-70)
chi angles: 285.7,308.2
0.038Å--
A 105 ALA24.45-Favored (57.02%)
General case / -66.0,-51.6
-0.077Å--
A 106 LYS90.1-Favored (73.56%)
General case / -56.3,-49.7
18.9% (tptm)
chi angles: 186.6,86,177.2,284.5
0.02Å--
A 107 ARG45.72-Favored (70.8%)
General case / -59.3,-51.2
60.4% (ttt180)
chi angles: 187.3,182.4,162,173.7
0.12Å--
A 108 ALA20.79-Favored (98.04%)
General case / -60.7,-42.8
-0.019Å--
A 109 TYR50.67-Favored (51.91%)
General case / -67.2,-51.6
93.5% (t80)
chi angles: 177.1,78.1
0.089Å--
A 110 ARG61.650.46Å
CZ with A 211 ALA HB2
Favored (85.1%)
General case / -58.3,-41.7
57.3% (ttt-85)
chi angles: 186.1,171.9,164.4,262.3
0.062Å--
A 111 GLU38.28-Favored (86.25%)
General case / -65.2,-45.1
74.4% (mt-10)
chi angles: 276.2,176.6,169.6
0.343Å--
A 112 LEU34.3-Favored (80.45%)
General case / -57.8,-48.1
15.3% (mt)
chi angles: 273.9,166.2
0.04Å--
A 113 VAL35.46-Favored (62.67%)
Isoleucine or valine / -65.4,-51.5
46.3% (t)
chi angles: 168
0.119Å--
A 114 LEU36.47-Favored (84.93%)
General case / -63.3,-36.8
69.7% (mt)
chi angles: 293.3,182.2
0.152Å--
A 115 MET43.21-Favored (2.15%)
General case / -58.4,-10.5
38.9% (mtm)
chi angles: 280.2,177.3,306
0.104Å--
A 116 LYS91.96-Favored (12.59%)
General case / -105.8,-23.9
91% (mttt)
chi angles: 295.8,166,182.8,180.8
0.02Å--
A 117 CYS59.58-Favored (33.39%)
General case / -88.7,7.5
97% (m)
chi angles: 294.1
0.063Å--
A 118 VAL44.15-Favored (39.35%)
Isoleucine or valine / -131.2,143.9
29.6% (m)
chi angles: 295
0.179Å--
A 119 ASN56.48-Allowed (1.71%)
General case / -145.3,85.0
41.6% (t30)
chi angles: 180,39.3
0.072Å--
A 120 HIS26.42-Favored (15.44%)
General case / -154.6,137.5
50.4% (t-80)
chi angles: 197.1,277.2
0.032Å--
A 121 LYS60.37-Favored (64.37%)
General case / -67.3,-16.6
48.8% (pttt)
chi angles: 62.1,174.9,168.2,193.5
0.119Å--
A 122 ASN22.05-Favored (50.77%)
General case / -96.6,5.4
29.3% (m120)
chi angles: 302.1,126.5
0.14Å--
A 123 ILE15.39-Favored (49.85%)
Isoleucine or valine / -122.0,139.2
48.5% (mm)
chi angles: 303.3,297.7
0.045Å--
A 124 ILE28.690.57Å
CD1 with A 501 880 CL45B
Allowed (0.84%)
Isoleucine or valine / -43.2,136.8
4% (tt)
chi angles: 182,188.5
0.05Å--
A 125 SER43.22-Favored (46.94%)
General case / -130.8,134.5
33.1% (t)
chi angles: 183.8
0.102Å--
A 126 LEU23.33-Favored (31.81%)
General case / -86.4,138.4
15.2% (mt)
chi angles: 286.7,192.9
0.063Å--
A 127 LEU23.29-Favored (13.7%)
General case / -90.8,-37.4
0%
chi angles: 257.7,14.1
0.121Å--
A 128 ASN24.87-Favored (35.62%)
General case / -158.0,158.9
10.4% (t-20)
chi angles: 211.4,351.1
0.037Å--
A 129 VAL22.96-Favored (11.43%)
Isoleucine or valine / -146.0,130.5
2.3% (p)
chi angles: 47.6
0.158Å--
A 130 PHE17.61-Favored (41.3%)
General case / -155.0,161.8
52% (p90)
chi angles: 65.5,90.6
0.046Å--
A 131 THR20.79-Favored (24.76%)
Pre-proline / -131.1,133.5
6% (t)
chi angles: 177.4
0.144Å--
A 132 PRO27.97-Favored (32.85%)
Trans proline / -70.5,-19.4
3.9% (Cg_exo)
chi angles: 355.4,21.1,91.5
0.05Å--
A 133 GLN32.66-Favored (36.55%)
General case / -79.4,134.8
13.8% (mp0)
chi angles: 295.6,94.6,37.2
0.121Å--
A 134 LYS92.32-Favored (28.57%)
General case / -83.7,-28.1
86.7% (mttt)
chi angles: 297.9,171.3,194.2,177.8
0.028Å--
A 135 THR43.24-Favored (35.31%)
General case / -128.9,159.6
67.8% (p)
chi angles: 59.4
0.061Å--
A 136 LEU45.95-Favored (84.8%)
General case / -59.8,-39.4
35.4% (tp)
chi angles: 168.6,63.8
0.021Å--
A 137 GLU81.48-Favored (96.14%)
General case / -63.1,-39.9
1%
chi angles: 232.3,47.8,57.3
0.121Å--
A 138 GLU61.6-Favored (42.42%)
General case / -83.1,-17.6
46.8% (mt-10)
chi angles: 294.4,173.9,100.3
0.047Å--
A 139 PHE25.31-Favored (8.37%)
General case / -48.9,124.3
38.3% (t80)
chi angles: 175.7,57.6
0.101Å--
A 140 GLN55.92-Allowed (0.89%)
General case / -133.6,-54.0
34.2% (mt-30)
chi angles: 290.8,204.5,70.6
0.027Å--
A 141 ASP25.74-Favored (39.5%)
General case / -114.8,147.7
20.6% (m-20)
chi angles: 311.9,128.1
0.028Å--
A 142 VAL16.24-Favored (72.13%)
Isoleucine or valine / -119.9,131.5
83.9% (t)
chi angles: 174.8
0.014Å--
A 143 TYR20.01-Favored (56.69%)
General case / -114.5,129.8
76.9% (m-85)
chi angles: 294.2,80.7
0.001Å--
A 144 LEU17.81-Favored (50.96%)
General case / -116.4,138.9
49.8% (mt)
chi angles: 305.9,172.2
0.04Å--
A 145 VAL14.29-Favored (63.69%)
Isoleucine or valine / -123.8,135.4
29.1% (t)
chi angles: 186.3
0.067Å--
A 146 MET14.24-Favored (12.35%)
General case / -143.1,172.7
26.2% (ptm)
chi angles: 70.7,175.5,280.4
0.017Å--
A 147 GLU48.7-Favored (52.54%)
General case / -56.1,136.7
14.9% (tt0)
chi angles: 205.3,196.5,141.4
0.191Å--
A 148 LEU19.43-Favored (26.33%)
General case / -73.6,124.7
53.3% (tp)
chi angles: 181.3,66
0.041Å--
A 149 MET21.58-Favored (13.94%)
General case / -97.4,161.1
77.3% (mmm)
chi angles: 306.8,289.7,280.8
0.121Å--
A 150 ASP27.54-Favored (23.34%)
General case / -84.8,-32.4
73.9% (m-20)
chi angles: 295.4,137
0.054Å--
A 151 ALA18.02-Favored (31.35%)
General case / -160.0,165.8
-0.079Å--
A 152 ASN28.3-Favored (7.03%)
General case / -98.3,173.4
50.9% (p30)
chi angles: 63.1,20.5
0.104Å--
A 153 LEU18.39-Favored (61.64%)
General case / -72.0,-21.1
12.1% (tp)
chi angles: 204.6,54.8
0.078Å--
A 154 CYS22.9-Favored (81.32%)
General case / -60.0,-48.5
94.3% (m)
chi angles: 294.9
0.018Å--
A 155 GLN41.63-Favored (96.43%)
General case / -61.4,-44.9
73.6% (mt-30)
chi angles: 295.1,170.3,289.7
0.059Å--
A 156 VAL26.17-Favored (78.71%)
Isoleucine or valine / -60.5,-38.6
55.1% (t)
chi angles: 169.8
0.127Å--
A 157 ILE21.44-Favored (72.67%)
Isoleucine or valine / -60.8,-36.6
6.3% (mt)
chi angles: 273.6,159.1
0.095Å--
A 158 GLN63.88-Favored (33.75%)
General case / -71.3,-5.6
65.4% (mt-30)
chi angles: 290.5,178.8,276.6
0.016Å--
A 159 MET37.85-Favored (20.19%)
General case / -115.0,160.0
20.2% (ptp)
chi angles: 62.1,193,72.9
0.139Å--
A 160 GLU41.97-Favored (34.7%)
General case / -81.9,129.3
69.9% (mt-10)
chi angles: 277.5,184,3.3
0.11Å--
A 161 LEU29.62-Favored (37.37%)
General case / -114.0,148.2
42.2% (mt)
chi angles: 294.1,162.1
0.078Å--
A 162 ASP49.94-Favored (13.03%)
General case / -80.3,173.0
11.7% (p-10)
chi angles: 59.9,118.3
0.063Å--
A 163 HIS26.77-Favored (68.77%)
General case / -69.0,-30.4
96.7% (m-70)
chi angles: 293.2,285.7
0.079Å--
A 164 GLU67.86-Favored (70.78%)
General case / -63.6,-50.1
13.5% (tt0)
chi angles: 172,201.2,98.8
0.022Å--
A 165 ARG72.38-Favored (67.29%)
General case / -69.6,-46.0
83% (mtt85)
chi angles: 288.7,179.5,181.5,89.6
0.093Å--
A 166 MET36.64-Favored (75.59%)
General case / -60.4,-49.9
48.5% (ttm)
chi angles: 195.3,183.3,287
0.139Å--
A 167 SER18.13-Favored (85.56%)
General case / -63.9,-36.9
84.4% (p)
chi angles: 68.5
0.076Å--
A 168 TYR27.14-Favored (90.38%)
General case / -64.6,-44.5
23.9% (t80)
chi angles: 184.7,50.2
0.082Å--
A 169 LEU18.88-Favored (94.97%)
General case / -60.1,-42.5
60.1% (mt)
chi angles: 295.2,165.2
0.055Å--
A 170 LEU15.11-Favored (79.86%)
General case / -68.6,-41.4
34% (mt)
chi angles: 293.3,159.9
0.042Å--
A 171 TYR34.63-Favored (83.11%)
General case / -57.2,-43.9
40% (t80)
chi angles: 164.3,76.8
0.017Å--
A 172 GLN23.9-Favored (89.64%)
General case / -66.3,-39.8
42.9% (mt-30)
chi angles: 287.6,176.1,94.8
0.068Å--
A 173 MET20.48-Favored (90.56%)
General case / -61.6,-46.3
14.7% (mtt)
chi angles: 290.3,174.2,234.4
0.034Å--
A 174 LEU17.53-Favored (90.48%)
General case / -62.0,-38.9
39.3% (mt)
chi angles: 294.3,161.5
0.108Å--
A 175 CYS22.92-Favored (79.26%)
General case / -62.1,-48.7
57.5% (m)
chi angles: 285.3
0.01Å--
A 176 GLY18.31-Favored (49.57%)
Glycine / -57.1,-52.7
----
A 177 ILE23.41-Favored (92.39%)
Isoleucine or valine / -59.9,-47.2
13.1% (mt)
chi angles: 293.3,146.2
0.083Å--
A 178 LYS48.71-Favored (73%)
General case / -54.6,-44.5
19.4% (tptt)
chi angles: 165,93,166.8,155.8
0.031Å--
A 179 HIS27.64-Favored (97.96%)
General case / -61.1,-44.0
62.2% (t60)
chi angles: 193.4,71.6
0.041Å--
A 180 LEU23.49-Favored (93.19%)
General case / -60.6,-45.6
57.6% (mt)
chi angles: 292.7,184
0.065Å--
A 181 HIS27.11-Favored (88.28%)
General case / -60.4,-39.7
55.6% (m170)
chi angles: 291.7,176.6
0.056Å--
A 182 SER34.9-Favored (68.15%)
General case / -64.8,-26.0
53.5% (p)
chi angles: 74.3
0.045Å--
A 183 ALA35.8-Favored (43.72%)
General case / -96.8,8.7
-0.026Å--
A 184 GLY30.08-Favored (83.25%)
Glycine / 78.7,13.3
----
A 185 ILE31.67-Favored (29.68%)
Isoleucine or valine / -95.9,113.2
16.3% (mt)
chi angles: 301.7,149.5
0.125Å--
A 186 ILE28.05-Favored (29.76%)
Isoleucine or valine / -109.0,109.8
58.1% (mt)
chi angles: 301.5,162.3
0.185Å--
A 187 HIS16.44-Allowed (0.27%)
General case / -55.9,-67.7
40.6% (t-80)
chi angles: 202,290.5
0.103Å--
A 188 ARG54.2-Allowed (1.97%)
General case / 74.5,-6.1
62.9% (mtm180)
chi angles: 289.5,193.3,291.1,156.6
0.134Å--
A 189 ASP33.25-Favored (2.68%)
General case / -136.6,35.3
27.2% (t0)
chi angles: 201.5,15.5
0.12Å--
A 190 LEU20.69-Favored (54.83%)
General case / -63.5,134.0
22.1% (mt)
chi angles: 282.3,159.2
0.1Å--
A 191 LYS52.27-Favored (35.59%)
Pre-proline / -148.7,151.4
7.3% (ptpt)
chi angles: 64.8,192.2,98.7,183.6
0.102Å--
A 192 PRO14.67-Favored (62.16%)
Trans proline / -64.5,-26.4
20.9% (Cg_endo)
chi angles: 19.4,331.2,146.5
0.085Å--
A 193 SER19.9-Favored (65.58%)
General case / -67.1,-19.2
99.4% (p)
chi angles: 64.4
0.023Å--
A 194 ASN22.65-Favored (19.06%)
General case / -103.7,19.9
70.9% (m-20)
chi angles: 281.1,320.5
0.096Å--
A 195 ILE14.39-Favored (67.07%)
Isoleucine or valine / -128.5,127.5
36.7% (mt)
chi angles: 302.7,158.2
0.067Å--
A 196 VAL12.85-Favored (21.88%)
Isoleucine or valine / -119.4,153.4
4.6% (m)
chi angles: 284.5
0.148Å--
A 197 VAL18.43-Favored (42.74%)
Isoleucine or valine / -133.4,158.1
10.3% (m)
chi angles: 308.3
0.084Å--
A 198 LYS71.27-Favored (13.63%)
General case / -109.1,163.1
37.6% (mtmt)
chi angles: 276.3,203.1,282,186
0.059Å--
A 199 SER47.87-Favored (37.33%)
General case / -56.4,-23.3
75.7% (m)
chi angles: 294.5
0.017Å--
A 200 ASP39.8-Favored (20.2%)
General case / -87.6,9.8
50.6% (p-10)
chi angles: 66.6,174.6
0.068Å--
A 201 CYS36.44-Favored (3.84%)
General case / 75.5,8.0
0.5%
chi angles: 217
0.112Å--
A 202 THR30.89-Favored (40.48%)
General case / -76.7,142.8
72.2% (p)
chi angles: 63.4
0.172Å--
A 203 LEU14.54-Favored (51.55%)
General case / -129.7,148.0
8.3% (tt)
chi angles: 176.7,151.6
0.112Å--
A 204 LYS28.84-Favored (36.74%)
General case / -139.0,137.9
61.5% (mttm)
chi angles: 298.9,185.6,193.4,288.7
0.025Å--
A 205 ILE13.19-Favored (41.5%)
Isoleucine or valine / -89.1,127.9
90.9% (mt)
chi angles: 299.3,171.7
0.089Å--
A 206 LEU13.31-Favored (27.5%)
General case / -85.2,-25.2
28.8% (mt)
chi angles: 302.7,164.1
0.051Å--
A 207 ASP23.47-Favored (7.12%)
General case / -124.3,175.4
5.6% (p-10)
chi angles: 76.7,138.9
0.055Å--
A 208 PHE20.51-Favored (14.03%)
General case / -116.8,9.7
96.9% (m-85)
chi angles: 298.3,93.7
0.096Å--
A 209 GLY25.52-Favored (32.87%)
Glycine / 80.1,-151.1
----
A 210 LEU41.62-Favored (21.97%)
General case / -83.4,-38.4
73.3% (mt)
chi angles: 302.4,173.5
0.063Å--
A 211 ALA48.820.46Å
HB2 with A 110 ARG CZ
Allowed (0.23%)
General case / 67.7,165.8
-0.056Å--
A 212 ARG119.41---0.043Å--
A 217 SER83.91--58.2% (p)
chi angles: 55.7
0.059Å--
A 218 PHE75.86-Favored (36.57%)
General case / -99.7,138.6
48.8% (t80)
chi angles: 166.6,73.7
0.054Å--
A 219 MET75.9-Favored (44.2%)
General case / -132.2,133.4
15.2% (ttm)
chi angles: 214.7,181.8,277.9
0.032Å--
A 220 MET89.23-Favored (36.94%)
General case / -82.2,1.3
3.8% (mmt)
chi angles: 267.9,281,191.5
0.021Å--
A 221 THR85.04-Favored (67.69%)
Pre-proline / -81.8,158.7
74.3% (p)
chi angles: 61.8
0.091Å--
A 222 PRO86.95-Favored (7.93%)
Trans proline / -84.2,2.9
28% (Cg_endo)
chi angles: 20.7,352.3,111.8
0.059Å--
A 223 TYR84.18-Favored (56.54%)
General case / -67.9,140.1
62.9% (m-85)
chi angles: 284.2,86.6
0.015Å--
A 224 VAL70.79-Favored (66.93%)
Isoleucine or valine / -110.9,129.0
14% (t)
chi angles: 190.9
0.13Å--
A 225 VAL52.44-Favored (37.39%)
Isoleucine or valine / -76.1,129.1
36.3% (t)
chi angles: 185.7
0.136Å--
A 226 THR33.92-Favored (11.82%)
General case / -73.0,115.0
90.2% (m)
chi angles: 300.7
0.111Å--
A 227 ARG85.74-Favored (16.09%)
General case / -108.0,-7.6
71.9% (mtt85)
chi angles: 287.4,176.6,191.6,92.8
0.034Å--
A 228 TYR43.58-Allowed (2%)
General case / -46.3,-30.2
5.4% (m-85)
chi angles: 316.3,136.5
0.062Å--
A 229 TYR16.77-Favored (31.85%)
General case / -101.9,-1.5
27.8% (m-85)
chi angles: 311.2,88.4
0.061Å--
A 230 ARG36.66-Favored (44.92%)
General case / -72.9,134.8
87.1% (mtt180)
chi angles: 282.9,174.3,196,184.3
0.123Å--
A 231 ALA21.48-Favored (98.35%)
Pre-proline / -67.3,149.5
-0.031Å--
A 232 PRO29.69-Favored (70.82%)
Trans proline / -52.1,-39.5
64.7% (Cg_exo)
chi angles: 334.1,36.7,87.7
0.022Å--
A 233 GLU36.59-Favored (65.98%)
General case / -66.1,-19.9
12.5% (pm0)
chi angles: 60.7,267.2,43.5
0.163Å--
A 234 VAL33.78-Favored (16.69%)
Isoleucine or valine / -86.0,-44.1
83.3% (t)
chi angles: 174.8
0.104Å--
A 235 ILE42.46-Favored (78.13%)
Isoleucine or valine / -58.2,-40.6
59.1% (mt)
chi angles: 295.4,159.1
0.05Å--
A 236 LEU39.11-Favored (43.62%)
General case / -99.8,9.1
37.1% (mt)
chi angles: 307.3,170.7
0.072Å--
A 237 GLY40.15-Favored (90.3%)
Glycine / 56.5,44.8
----
A 238 MET48.76-Favored (6.18%)
General case / -96.2,176.2
12.5% (ttm)
chi angles: 210.9,176.2,313.4
0.237Å--
A 239 GLY34.32-Favored (54.2%)
Glycine / -75.0,163.3
----
A 240 TYR32.88-Favored (44.64%)
General case / -142.7,154.8
54.7% (p90)
chi angles: 63,88.7
0.028Å--
A 241 LYS56.1-Favored (2.35%)
General case / -121.8,-172.0
52.1% (pttt)
chi angles: 63.9,183.8,170.6,168.3
0.145Å--
A 242 GLU54.95-Favored (64.22%)
General case / -52.5,-42.2
45.4% (mp0)
chi angles: 282.3,82.7,173.4
0.045Å--
A 243 ASN25.47-Allowed (1.6%)
General case / -68.5,3.9
40.1% (p-10)
chi angles: 72.4,357.1
0.159Å--
A 244 VAL20.3-Favored (53.35%)
Isoleucine or valine / -58.8,-34.9
9.5% (p)
chi angles: 72.7
0.079Å--
A 245 ASP19.72-Favored (61.16%)
General case / -72.3,-23.5
75.9% (m-20)
chi angles: 290.9,143.1
0.096Å--
A 246 ILE12.94-Favored (67.11%)
Isoleucine or valine / -66.1,-34.0
11% (mm)
chi angles: 284.3,288.3
0.124Å--
A 247 TRP14.82-Favored (90.96%)
General case / -62.6,-45.9
30.7% (t-105)
chi angles: 173.2,274.5
0.044Å--
A 248 SER15.38-Favored (95.39%)
General case / -62.7,-39.9
17.3% (m)
chi angles: 307.2
0.014Å--
A 249 VAL12.75-Favored (87.81%)
Isoleucine or valine / -63.5,-40.1
84.5% (t)
chi angles: 174.9
0.077Å--
A 250 GLY12.11-Favored (96.12%)
Glycine / -60.5,-45.5
----
A 251 CYS12.65-Favored (96.24%)
General case / -60.2,-43.0
84.6% (m)
chi angles: 292.4
0.009Å--
A 252 ILE15.83-Favored (75.53%)
Isoleucine or valine / -67.4,-49.0
87.1% (mt)
chi angles: 292.1,165.6
0.122Å--
A 253 MET19.82-Favored (88.7%)
General case / -59.3,-46.4
26.3% (ttt)
chi angles: 179.4,178.4,184.3
0.028Å--
A 254 GLY20.08-Favored (94.15%)
Glycine / -57.7,-42.0
----
A 255 GLU29.64-Favored (72.32%)
General case / -69.7,-33.3
60.8% (tt0)
chi angles: 190.3,170.4,155.6
0.024Å--
A 256 MET35.21-Favored (85.06%)
General case / -63.5,-36.8
6.5% (mtp)
chi angles: 269.9,156.3,97
0.032Å--
A 257 VAL30.27-Favored (18.17%)
Isoleucine or valine / -77.7,-51.4
78.8% (t)
chi angles: 172.6
0.122Å--
A 258 ARG42.76-Favored (59.37%)
General case / -75.0,-26.2
54.9% (mtt180)
chi angles: 286.8,203.7,187,156.5
0.06Å--
A 259 HIS32.37-Favored (9.78%)
General case / 67.2,22.2
79.8% (m-70)
chi angles: 309,284.9
0.186Å--
A 260 LYS90.87-Favored (27.96%)
General case / -146.0,141.7
38.5% (mtmt)
chi angles: 278.6,186.3,268.4,182.3
0.065Å--
A 261 ILE28.73-Favored (13.86%)
Isoleucine or valine / -53.2,129.4
53.1% (mt)
chi angles: 299.7,159.7
0.046Å--
A 262 LEU24.28-Favored (63.66%)
General case / -66.5,-50.3
20.3% (mt)
chi angles: 292.9,192.4
0.047Å--
A 263 PHE29.37-Favored (57.85%)
Pre-proline / -124.1,80.9
11.5% (m-85)
chi angles: 319.5,111.8
0.106Å--
A 264 PRO41.61-Favored (4.9%)
Trans proline / -84.2,73.1
76.7% (Cg_endo)
chi angles: 29.7,335.6,129.3
0.072Å--
A 265 GLY41.71-Favored (12.92%)
Glycine / -86.6,135.0
----
A 266 ARG96.16-Favored (60.6%)
General case / -74.4,-18.8
21.9% (ptt180)
chi angles: 48.3,167.3,165.9,168.7
0.076Å--
A 267 ASP62.67-Favored (16.63%)
General case / -157.7,173.6
1.8% (p30)
chi angles: 52.9,72.2
0.032Å--
A 268 TYR47.59-Favored (77.87%)
General case / -59.7,-37.1
3% (m-85)
chi angles: 274.9,141.6
0.093Å--
A 269 ILE51.67-Favored (10.25%)
Isoleucine or valine / -61.9,-57.8
15.2% (mm)
chi angles: 298.9,284.2
0.055Å--
A 270 ASP52.94-Favored (76.45%)
General case / -55.5,-44.4
21.6% (t0)
chi angles: 195.9,39.2
0.028Å--
A 271 GLN58.01-Favored (45.42%)
General case / -54.1,-54.0
7.5% (tp-100)
chi angles: 186.6,78.2,234.4
0.073Å--
A 272 TRP31.36-Favored (81.9%)
General case / -58.6,-39.9
74.4% (t-105)
chi angles: 183.3,247.9
0.13Å--
A 273 ASN44.75-Favored (92.17%)
General case / -62.8,-45.5
90% (m-20)
chi angles: 294.6,322.2
0.089Å--
A 274 LYS71.58-Favored (77.03%)
General case / -62.3,-34.7
36.7% (mmtm)
chi angles: 301.4,279.4,198.5,291
0.032Å--
A 275 VAL24.62-Favored (22.03%)
Isoleucine or valine / -67.1,-54.7
40.2% (t)
chi angles: 166.5
0.068Å--
A 276 ILE40.63-Favored (65.27%)
Isoleucine or valine / -66.9,-33.7
18.8% (pt)
chi angles: 68.9,161.6
0.222Å--
A 277 GLU64.97-Favored (71.81%)
General case / -60.4,-32.9
25% (mt-10)
chi angles: 274.9,157,26.8
0.072Å--
A 278 GLN44.98-Favored (5.1%)
General case / -97.4,-48.9
70.1% (mt-30)
chi angles: 289,179.5,63.4
0.063Å--
A 279 LEU29.56-Favored (24.45%)
General case / -91.4,-18.3
53.7% (mt)
chi angles: 307.9,179.6
0.05Å--
A 280 GLY31.64-Favored (37.93%)
Glycine / 93.7,167.8
----
A 281 THR39.92-Favored (92.59%)
Pre-proline / -64.1,128.1
28.7% (m)
chi angles: 307.6
0.114Å--
A 282 PRO40.73-Favored (28.56%)
Trans proline / -67.5,165.1
59.2% (Cg_endo)
chi angles: 26.8,325.5,147.8
0.026Å--
A 283 CYS43.77-Favored (6.82%)
Pre-proline / -56.8,159.6
26.8% (p)
chi angles: 66.9
0.037Å--
A 284 PRO47.64-Favored (50.83%)
Trans proline / -65.7,-30.2
18% (Cg_exo)
chi angles: 345.3,29.3,88.2
0.035Å--
A 285 GLU44.34-Favored (71.38%)
General case / -59.4,-33.6
-0.021Å--
A 286 PHE37.84-Favored (72.52%)
General case / -70.0,-42.9
84.8% (t80)
chi angles: 174.5,80.8
0.038Å--
A 287 MET50.11-Favored (76.27%)
General case / -58.1,-38.3
12.7% (mmt)
chi angles: 309.2,301.6,195.6
0.035Å--
A 288 LYS108.79-Favored (64.81%)
General case / -59.7,-25.4
57% (mttm)
chi angles: 285.7,186.3,189.1,281.8
0.055Å--
A 289 LYS66-Favored (50.33%)
General case / -88.7,-9.9
46% (mtmt)
chi angles: 300,189.4,275.8,174.9
0.078Å--
A 290 LEU49.66-Favored (28.79%)
General case / -81.3,149.7
39.2% (mt)
chi angles: 290,160.7
0.022Å--
A 291 GLN96.39-Favored (95.69%)
Pre-proline / -62.0,141.3
0%
chi angles: 215,245.3,91.8
0.06Å--
A 292 PRO61.99-Favored (11.71%)
Trans proline / -43.8,-44.3
86.7% (Cg_exo)
chi angles: 331.6,31.8,98.3
0.071Å--
A 293 THR61.41-Favored (72.52%)
General case / -66.1,-48.0
47.3% (p)
chi angles: 66.2
0.145Å--
A 294 VAL44.71-Favored (98.2%)
Isoleucine or valine / -63.7,-43.8
6.7% (t)
chi angles: 193.6
0.166Å--
A 295 ARG101.09-Favored (76.76%)
General case / -55.6,-47.2
66.4% (ttt180)
chi angles: 186.8,180.1,187.1,165.8
0.067Å--
A 296 ASN82.31-Favored (95.32%)
General case / -61.1,-45.3
26.8% (t-20)
chi angles: 179.9,271.2
0.032Å--
A 297 TYR61.04-Favored (96.15%)
General case / -63.5,-43.8
78.3% (t80)
chi angles: 172.3,75.4
0.07Å--
A 298 VAL49.5-Favored (81.08%)
Isoleucine or valine / -69.4,-43.2
65.5% (t)
chi angles: 171.4
0.177Å--
A 299 GLU87.19-Favored (62.3%)
General case / -71.1,-20.8
84.2% (mt-10)
chi angles: 282,184.8,164.9
0.064Å--
A 300 ASN78.19-Favored (47.5%)
General case / -98.9,5.1
7.8% (m120)
chi angles: 277.6,87.8
0.127Å--
A 301 ARG100.73-Favored (83.11%)
Pre-proline / -76.7,155.7
0%
chi angles: 236.5,35.4,193.1,99.2
0.046Å--
A 302 PRO60.1-Favored (21.64%)
Trans proline / -61.6,127.4
18.6% (Cg_exo)
chi angles: 345.2,28.8,89.3
0.048Å--
A 303 LYS95.38-Favored (47.17%)
General case / -69.8,150.1
7.6% (mptt)
chi angles: 282.9,92.2,191.9,172.5
0.1Å--
A 304 TYR65.66-Favored (21.42%)
General case / -142.7,130.3
56.9% (m-85)
chi angles: 284.4,101.2
0.026Å--
A 305 ALA38.45-Favored (70.04%)
General case / -67.5,-30.4
-0.053Å--
A 306 GLY36.38-Favored (39.62%)
Glycine / 86.0,164.7
----
A 307 LEU42.85-Favored (25.78%)
General case / -99.1,146.8
0.6%
chi angles: 272.5,30.3
0.053Å--
A 308 THR36.79-Favored (37.89%)
General case / -73.2,157.1
28.5% (p)
chi angles: 70.9
0.033Å--
A 309 PHE32.99-Favored (19.32%)
Pre-proline / -65.3,-37.3
32.9% (m-85)
chi angles: 277.5,84
0.214Å--
A 310 PRO38.52-Favored (97.57%)
Trans proline / -59.4,-34.0
34.3% (Cg_exo)
chi angles: 338.4,34.1,87.3
0.033Å--
A 311 LYS88.68-Favored (61.79%)
General case / -72.6,-44.6
26.6% (mttp)
chi angles: 262.3,173.7,163.6,69.1
0.052Å--
A 312 LEU41.14-Favored (96.82%)
General case / -61.0,-44.8
36.6% (mt)
chi angles: 286.7,160.6
0.022Å--
A 313 PHE34.67-Favored (57.13%)
Pre-proline / -123.8,76.2
78.8% (m-85)
chi angles: 304.4,97.5
0.049Å--
A 314 PRO41.31-Favored (26.21%)
Trans proline / -62.1,161.5
32.3% (Cg_exo)
chi angles: 339.6,34.5,85.3
0.074Å--
A 315 ASP63.8-Favored (30.11%)
General case / -50.1,-36.6
72.9% (m-20)
chi angles: 298.8,162
0.03Å--
A 316 SER61.66-Favored (30.1%)
General case / -48.8,-40.6
2.3% (m)
chi angles: 319.2
0.05Å--
A 317 LEU42.13-Favored (62.21%)
General case / -71.7,-18.1
88.6% (mt)
chi angles: 300.2,178.9
0.064Å--
A 318 PHE51.27-Favored (42.16%)
Pre-proline / -111.8,98.6
97.5% (m-85)
chi angles: 298.1,94.1
0.038Å--
A 319 PRO58.25-Allowed (0.11%)
Trans proline / -66.6,17.1
19.2% (Cg_exo)
chi angles: 345,32.8,83.1
0.079Å--
A 320 ALA55.74-OUTLIER (0%)
General case / -27.8,82.1
-0.067Å- OUTLIER(S)
worst is C-N-CA: 4.184 σ
A 321 ASP69.53-Allowed (1.01%)
General case / -83.1,-65.5
2.2% (p-10)
chi angles: 43,121.6
0.105Å--
A 322 SER40.58-Favored (15.12%)
General case / -74.2,170.6
46.3% (p)
chi angles: 75.9
0.028Å--
A 323 GLU37.69-Favored (82.3%)
General case / -68.2,-39.6
64.4% (mm-40)
chi angles: 287.4,291.9,170.4
0.036Å--
A 324 HIS39.26-Favored (55.6%)
General case / -51.9,-51.6
57% (t60)
chi angles: 170.1,89.3
0.021Å--
A 325 ASN40.7-Favored (81.94%)
General case / -66.6,-36.2
91.1% (m-20)
chi angles: 283.5,341.4
0.106Å--
A 326 LYS39.85-Favored (97%)
General case / -61.0,-44.7
76.4% (mttt)
chi angles: 282.5,183.2,169.1,160.4
0.025Å--
A 327 LEU30.98-Favored (71.93%)
General case / -68.7,-45.3
41.5% (tp)
chi angles: 182.2,55.6
0.049Å--
A 328 LYS55.6-Favored (84.48%)
General case / -62.5,-37.0
14.5% (mmtt)
chi angles: 291.8,277,139.3,204
0.073Å--
A 329 ALA21.4-Favored (96.02%)
General case / -62.8,-44.5
-0.038Å--
A 330 SER32.45-Favored (93.58%)
General case / -59.6,-44.0
5.6% (t)
chi angles: 161.1
0.033Å--
A 331 GLN27.58-Favored (75.42%)
General case / -70.0,-36.8
95.4% (mt-30)
chi angles: 295,173.3,341.7
0.069Å--
A 332 ALA19.3-Favored (91.98%)
General case / -63.7,-45.0
-0.05Å--
A 333 ARG74.18-Favored (90.79%)
General case / -65.8,-39.2
22.6% (ttm105)
chi angles: 194.8,197.8,281.4,107.2
0.12Å--
A 334 ASP30.66-Favored (94.23%)
General case / -60.5,-41.4
37.3% (t70)
chi angles: 183.2,67.6
0.023Å--
A 335 LEU20.23-Favored (80.37%)
General case / -68.2,-42.2
57.1% (tp)
chi angles: 180.3,59.5
0.084Å--
A 336 LEU23.03-Favored (84.93%)
General case / -57.5,-44.1
10.6% (mt)
chi angles: 268.5,169.2
0.063Å--
A 337 SER18.39-Favored (64.91%)
General case / -60.4,-24.2
23.9% (p)
chi angles: 79.5
0.081Å--
A 338 LYS34.47-Favored (17.16%)
General case / -94.5,-24.6
54% (mttm)
chi angles: 291.8,177.1,189.3,315.5
0.053Å--
A 339 MET18.39-Favored (13.86%)
General case / -88.9,-39.3
67.6% (mtm)
chi angles: 300,196.4,293.9
0.038Å--
A 340 LEU17.9-Favored (6.17%)
General case / -87.6,60.8
60.9% (mt)
chi angles: 285.1,171.5
0.054Å--
A 341 VAL21.19-Favored (63.61%)
Isoleucine or valine / -116.8,120.0
94.2% (t)
chi angles: 176.8
0.072Å--
A 342 ILE23.01-Favored (80.77%)
Isoleucine or valine / -56.9,-48.8
68.4% (mt)
chi angles: 297.3,161.8
0.148Å--
A 343 ASP40.8-Favored (30.84%)
Pre-proline / -75.8,113.8
54.4% (t0)
chi angles: 191.2,175.9
0.066Å--
A 344 PRO27.21-Favored (73.69%)
Trans proline / -63.0,-22.2
19.6% (Cg_endo)
chi angles: 17.6,333.7,144.1
0.064Å--
A 345 ALA32.73-Favored (65.66%)
General case / -67.2,-23.0
-0.021Å--
A 346 LYS63.34-Favored (14.77%)
General case / -113.4,0.4
21.4% (mtmm)
chi angles: 292.7,188.6,262.9,290
0.019Å--
A 347 ARG25.46-Favored (30.52%)
General case / -88.3,139.4
34.4% (ttm180)
chi angles: 191.9,186.7,303.3,148.8
0.089Å--
A 348 ILE31.72-Favored (8.81%)
Isoleucine or valine / -58.4,146.1
9.6% (tt)
chi angles: 201.4,177.7
0.134Å--
A 349 SER24.64-Favored (12.55%)
General case / -84.5,171.4
93.9% (p)
chi angles: 63.3
0.062Å--
A 350 VAL19.35-Favored (99.38%)
Isoleucine or valine / -62.9,-45.2
47.3% (t)
chi angles: 168.2
0.147Å--
A 351 ASP38.56-Favored (93.69%)
General case / -60.5,-41.1
90.6% (m-20)
chi angles: 284.5,169.4
0.082Å--
A 352 ASP33.92-Favored (64.73%)
General case / -73.9,-35.5
88% (m-20)
chi angles: 293.8,154.8
0.135Å--
A 353 ALA20.13-Favored (82.34%)
General case / -60.7,-37.6
-0.019Å--
A 354 LEU25.88-Favored (62.01%)
General case / -71.2,-22.6
20.5% (mt)
chi angles: 283.9,157.7
0.033Å--
A 355 GLN74.51-Favored (41.97%)
General case / -93.4,-8.4
14.2% (mm100)
chi angles: 290.5,276.1,71.3
0.031Å--
A 356 HIS23.36-Favored (97.2%)
Pre-proline / -65.2,138.5
65.6% (t-80)
chi angles: 189.2,280.3
0.036Å--
A 357 PRO29.29-Favored (67.86%)
Trans proline / -52.4,-36.0
71.6% (Cg_exo)
chi angles: 333.8,35.2,90.5
0.049Å--
A 358 TYR23.37-Favored (75.64%)
General case / -60.3,-35.5
28.7% (t80)
chi angles: 195.1,66.5
0.041Å--
A 359 ILE25-Favored (11.06%)
Isoleucine or valine / -96.4,-40.9
46.8% (mm)
chi angles: 305.2,301.3
0.082Å--
A 360 ASN67.03-Allowed (0.99%)
General case / -46.1,-27.5
6.6% (t-20)
chi angles: 216.1,7.8
0.03Å--
A 361 VAL32.37-Favored (36.93%)
Isoleucine or valine / -62.8,-24.9
9.8% (m)
chi angles: 308.6
0.166Å--
A 362 TRP31.03-Favored (23.38%)
General case / -94.7,-16.0
79% (m95)
chi angles: 304,109.3
0.02Å--
A 363 TYR42.7-Allowed (0.65%)
General case / -40.1,116.4
11.8% (t80)
chi angles: 201.2,98.9
0.132Å--
A 364 ASP45.61-Favored (12%)
Pre-proline / -135.4,116.5
63% (t0)
chi angles: 179.6,179.9
0.047Å--
A 365 PRO51.52-Favored (71.95%)
Trans proline / -55.6,-29.8
52.7% (Cg_exo)
chi angles: 334.9,37.8,84.9
0.052Å--
A 366 ALA42.95-Favored (67.14%)
General case / -67.4,-27.5
-0.023Å--
A 367 GLU57.71-Favored (12.54%)
General case / -92.3,-37.6
56.3% (mt-10)
chi angles: 307.6,170.8,143.1
0.023Å--
A 368 VAL41.17-Favored (14.62%)
Isoleucine or valine / -84.0,-39.2
89.5% (t)
chi angles: 177.9
0.081Å--
A 369 GLU82.4-Favored (4.43%)
General case / -111.2,33.8
18.5% (mt-10)
chi angles: 299.5,153.8,57.8
0.061Å--
A 370 ALA58.18-Favored (89.56%)
Pre-proline / -60.8,144.7
-0.036Å--
A 371 PRO70.41-Favored (45.53%)
Trans proline / -55.1,131.3
51.5% (Cg_exo)
chi angles: 336,35.9,87
0.05Å--
A 372 PRO74.17-Favored (3.31%)
Trans proline / -80.6,117.2
2.1% (Cg_endo)
chi angles: 5.4,13,94.2
0.019Å--
A 373 PRO73.02-Favored (17.61%)
Trans proline / -79.4,143.9
5.6% (Cg_exo)
chi angles: 358.1,22.8,85.7
0.057Å--
A 374 GLN108.33---0.041Å--
A 379 GLN94.74---0.042Å--
A 380 LEU95.98-Favored (7.32%)
General case / -131.3,104.9
2.5% (mp)
chi angles: 308.7,102
0.034Å--
A 381 ASP95.76-Favored (19.87%)
General case / -165.4,163.3
25.9% (t0)
chi angles: 198.1,30.2
0.026Å--
A 382 GLU82.56-OUTLIER (0.03%)
General case / 51.4,86.7
-0.102Å--
A 383 ARG76.26-Favored (4.52%)
General case / -162.7,132.7
-0.037Å--
A 384 GLU94.55-Favored (36.45%)
General case / -79.8,135.2
5.8% (pt-20)
chi angles: 62.3,160.6,93.5
0.065Å--
A 385 HIS57.81-Favored (47.53%)
General case / -139.6,154.3
95.7% (m-70)
chi angles: 292.4,289
0.056Å--
A 386 THR56.87-Favored (11.42%)
General case / -79.5,174.6
42.5% (p)
chi angles: 54.6
0.046Å--
A 387 ILE44.97-Favored (74.86%)
Isoleucine or valine / -57.0,-50.9
86.6% (mt)
chi angles: 292.3,165.2
0.059Å--
A 388 GLU65.98-Favored (83.07%)
General case / -57.4,-46.8
0%
chi angles: 23.5,152,68.3
0.115Å--
A 389 GLU56.44-Favored (85.44%)
General case / -64.0,-46.2
80.3% (mt-10)
chi angles: 293.5,160.3,166.2
0.019Å--
A 390 TRP28.83-Favored (93.27%)
General case / -60.7,-40.7
9.5% (m95)
chi angles: 280.1,129.7
0.023Å--
A 391 LYS54.64-Favored (80.77%)
General case / -57.0,-47.4
80% (tttt)
chi angles: 189.6,174.7,184.5,191.8
0.025Å--
A 392 GLU64.18-Favored (73.48%)
General case / -70.3,-41.3
19.7% (tt0)
chi angles: 204.3,175,88.6
0.097Å--
A 393 LEU40.06-Favored (98.78%)
General case / -62.4,-43.5
36.6% (mt)
chi angles: 288.8,160.2
0.079Å--
A 394 ILE32.26-Favored (78.82%)
Isoleucine or valine / -67.7,-47.7
55.3% (mt)
chi angles: 292.3,158
0.154Å--
A 395 TYR41.81-Favored (79.73%)
General case / -56.5,-43.3
70.5% (t80)
chi angles: 184.7,69.9
0.028Å--
A 396 LYS97.4-Favored (97.53%)
General case / -64.0,-41.5
86% (mttt)
chi angles: 278.6,171.3,182.1,174.1
0.056Å--
A 397 GLU59.92-Favored (98.63%)
General case / -63.5,-41.7
6.2% (tp10)
chi angles: 207.5,47.4,59.1
0.049Å--
A 398 VAL39.05-Favored (87.44%)
Isoleucine or valine / -67.2,-44.6
59.8% (t)
chi angles: 171
0.118Å--
A 399 MET52.8-Favored (58.37%)
General case / -75.7,-27.7
35.1% (mmt)
chi angles: 295.1,291.8,94.9
0.089Å--
A 400 ASN112.1--1.5% (m-20)
chi angles: 246.1,330.7
0.113Å--
A 502 ANP44.5------
A 501 88023.810.57Å
CL45B with A 124 ILE CD1
-----
A 601 HOH14.77------
A 602 HOH10.27------
A 603 HOH22.05------
A 604 HOH20.17------
A 605 HOH26.33------
A 606 HOH14.5------
A 607 HOH17.48------
A 608 HOH19.51------
A 609 HOH21.99------
A 610 HOH21.36------
A 611 HOH22.12------
A 612 HOH27.4------
A 613 HOH13.31------
A 614 HOH24.45------
A 615 HOH15.69------
A 616 HOH21.37------
A 617 HOH33.5------
A 619 HOH22.04------
A 621 HOH32.04------
A 622 HOH26.9------
A 623 HOH31.77------
A 624 HOH42.14------
A 625 HOH16.27------
A 626 HOH41.35------
A 627 HOH22.67------
A 628 HOH38.68------
A 629 HOH22.2------
A 631 HOH24.72------
A 632 HOH24.53------
A 633 HOH40.92------
A 634 HOH28.03------
A 639 HOH10.87------
A 640 HOH31.87------
A 641 HOH26.21------
A 642 HOH36.69------
A 646 HOH32.53------
A 647 HOH24.23------
A 648 HOH29.72------
A 649 HOH37.21------
A 651 HOH24.52------
A 654 HOH29.8------
A 655 HOH27.21------
A 656 HOH25.76------
A 658 HOH38.86------
A 659 HOH49.49------
A 663 HOH36.29------
A 664 HOH41.9------
A 665 HOH30.38------
A 669 HOH43.55------
A 671 HOH25.97------
A 677 HOH25.56------
A 680 HOH32.14------
A 681 HOH29.13------
A 682 HOH50.54------
A1001 HOH33.64------
A1002 HOH33.05------
A1003 HOH22.14------
A1004 HOH30.2------
A1005 HOH33.1------
A1006 HOH35.28------